Filing Details
- Accession Number:
- 0001209191-10-025155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-04 13:00:00
- Reporting Period:
- 2010-04-30
- Filing Date:
- 2010-05-04
- Accepted Time:
- 2010-05-04 17:36:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1107332 | Dendreon Corp | DNDN | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1171147 | G Douglas Watson | 3005 First Avenue Seattle WA 98121 | Board Of Director | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-30 | 28,671 | $4.90 | 54,921 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-30 | 28,671 | $56.56 | 26,250 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-04-30 | 7,500 | $26.64 | 33,750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-30 | 7,500 | $56.56 | 26,250 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option(right to buy) | Disposition | 2010-04-30 | 28,671 | $56.56 | 28,671 | $4.90 |
Common Stock | Non-Qualified Stock Option(right to buy) | Disposition | 2010-04-30 | 7,500 | $56.56 | 7,500 | $26.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-12-05 | No | 4 | M | Direct | |
0 | 2019-12-08 | No | 4 | M | Direct |
Footnotes
- All options are exercisable on date of grant.